The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with β thalassemia intermedia

Haematologica

Volumn 83, Issue 2, 1998, Pages 118-125

  De Franceschi, Lucia ^a   Cappellini, Maria Domenica ^b   Graziadei, Giovanna ^b   Manzato, Franco ^a   Olivieri, Oliviero ^a   Corrocher, Roberto ^a   Fiorelli, Gemino ^b   Beuzard, Yves ^c   Brugnara, Carlo ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAINT LOUIS HOSPITAL   (France)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Erythrocyte; Magnesium; Thalassemia; Transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHLORIDE ION; POTASSIUM ION; PYROGLUTAMATE MAGNESIUM;

ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG ERYTHROCYTE LEVEL; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERMAGNESEMIA; MAGNESIUM BLOOD LEVEL; METAL BINDING; ORAL DRUG ADMINISTRATION;

BETA-THALASSEMIA; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CHLORIDES; DIETARY SUPPLEMENTS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES, ABNORMAL; HUMANS; MAGNESIUM; POTASSIUM; POTASSIUM CHANNELS; SODIUM; SODIUM CHANNELS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; SYMPORTERS; TIME FACTORS;

EID: 0031942265     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Shinar E, Rachmilewitz EA. Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990; 27:70-82.
2. Scott MD, Eaton JW. Thalassemic erythrocytes: suicide arising from iron and glutathione-dependent oxidation reactions? Br J Haematol 1995; 91:811-9.
3. Weatherall DJ. Thalassemia. In: Beutler E, Lichtman MA, Coller BS, Kipps J, eds. Williams Hematology. New York: McGraw Hill, Inc. 1995. p. 581-615.
4. McDonagh KT, Nienhuis AW. The thalassemias. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia: Saunders & Co., 1993. p. 783-879.
5. + concentration are not impaired in β-thalassemic and hemoglobin C erythrocytes. Blood 1987; 70:804-8.
6. Bookchin RM, Ortiz OE, Shalev O, et al. Calcium transport and ultrastructured of red cells in β-thalassemia intermedia. Blood 1988; 72:1602-7.
7. Wiley JW. Increased erythrocytes cation permeability in thalassemia and conditions of bone marrow stress. J Clin Invest 1981; 67:917-22.
8. Gunn RB, Silvers DN, Rosse WF. Potassium permeability in β-thalassemia minor red blood cells. J Clin Invest 1972; 51:1043-50.
9. Vettore L, Falezza GC, Cetto GL, De Matteis MC. Cation content and membrane deformability of heterozygous β thalassaemic red blood cells. Br J Haematol 1974; 27:429-37.
10. Olivieri O, Vitoux D, Galacteros F, et al. Hemoglobin variants and activity of K/Gl cotransport system in human erythrocytes. Blood 1992; 79:793-7.
11. Olivieri O, De Franceschi L, Cappellini MD, Girelli D, Corrocher R, Brugnara C. Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood 1994; 84:315-20.
12. Olivieri O, Bonollo M, Friso S, Girelli D, Corrocher R, Vettore L. Activations of K/Cl cotransport in human erythrocytes exposed to oxidative agent. Biochim Biophys Acta 1993; 1176:37-42.
13. De Franceschi L, Shalev O, Piga A, et al. Deferiprone (Ll) treatment removes erythrocytes membrane free iron and affects K-Cl cotransport activity in homozygous β thalassemia [abstract]. Blood 1996c; 88:24b.
14. s-globin chains on cellular properties of red cells from β-thalassemic mice. J Clin Invest 1988; 82:1129-33.
15. Brugnara C, Kopin AK, Bunn HF, Tosteson DC. Regulation of cation content and cell volume in erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest 1985; 75:1608-17.
16. Brugnara C, Bunn HF, Tosteson DC. Regulation of erythrocyte cation and water content in sickle cell anemia. Science 1986; 232:388-90.
17. Canessa M, Fabry ME, Blumenfeld N, Nagel RL. Volume stimulated Cl-dependent K efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J Membrane Biol 1987a; 97:97-105.
18. Canessa M, Spalvins A, Nagel RL. Volume dependent and NEM stimulated K+, Cl-transport is elevated in oxygenated SS, SC, and CC human red cells. FEBS Letters 1986b; 200:197-202.
19. Brugnara C. Characteristics of the volume-and chloride-dependent K transport in human erythrocytes homozygous for hemoglobin C. J Membrane Biol 1989; 111:69-81.
20. Brugnara C, Tosteson DC. Cell volume, K transport and cell density in human erythrocytes. Am J Physiol 1987a; 252(Cell Physiology 21):C269-76.
21. Hebbel RP, Morgan WT, Eaton JW, Hedlund BE. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA 1988; 85:237-41.
22. Brugnara C, Tosteson DC. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood 1987b; 70:1810-5.
23. ++ modulation. Blood 1987b; 70:1861-6.
24. Flatman PW. The effects of magnesium on potassium transport in ferret red cells. J Physiol 1988; 397:471-87.
25. Flatman PW. Regulation of potassium transport by magnesium. In: Reuss L, Russell JM, Zabo G, eds. Regulation of potassium transport across biological membranes. Austin, TX: University of Texas Press, 1990. p. 191-7.
26. Rayssignier Y, Gueux E, Motta C. Magnesium deficiency effects on fluidity and function of plasma and subcellular membranes. In: Lasserre B, Durlach J, eds. Magnesium, a relevant ion. New York: John Libbey, 1991. p. 311-9.
27. Frenkel EJ, Graziani M, Schatzmann HJ. ATP requirement of the Na-dependent Mg extrusion from human red cells. J Physiol 1989; 414:385-97.
28. Freedman AM, Mak IT, Stafford RE, et al. Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am J Physiol (Cell Physiology 31) 1992; 262:C1317-75.
29. Mak IT, Stafford RE, Weglicki W. Loss of red blood cell gluthatione during Mg deficiency: prevention by vitamin E, d-proprandol and chloroquine. Am J Physiol 1994; 267(Cell Physiology 36): C1366-70.
30. De Franceschi L, Beuzard Y, Jouault H, Brugnara C. Modulation of erythrocyte potassium-chloride co-transport, potassium content and density by dietary magnesium intake in transgenic SAD mouse. Blood 1996a; 88:2738-44.
31. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocytes dehydration in patients with sickle cell disease. J Clin Invest 1997; 100:1847-52.
32. Hyman CB, Ortega JA, Costin G, Takahasi M. The clinical significance of magnesium in thalassemia. Ann NY Acad Sci 1980; 344:436-43.
33. Abbasciano V, Bader G, Graziano L, et al. Serum and erythrocyte levels of magnesium in mycrocytosis: comparison between heterozygous β thalassemia and sideropenic anemia. Haematologica 1991; 76:339-41.
34. De Franceschi L, Brugnara C, Beuzard Y. Dietary magnesium supplementation ameliorates anemia in a mouse model of β thalassemia. Blood 1997; 90:1283-90.
35. Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in random adult population sample. Lancet 1994; 344:357-62.
36. Paolisso G, Scheen A, Cazzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4 weeks magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78:1510-4.
37. Borella P, Ambrosini G, Concari M, Bargellini A. Is magnesium content in erythrocytes suitable for evaluating cation retention after oral physiological supplementation in marginally magnesium-deficient subjects? Magnesium Res 1993; 6:149-53.
38. Brugnara C, Gee B, Armsby CC, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996; 97:1227-34.
39. Danon D, Marikovsky Y. Determination of density distribution of red cell population. J Lab Clin Med 1964; 64:668-73.
40. Tongyai S, Rayssiguier Y, Motta C, Gueux E, Maurois P, Heaton FW. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol (Cell Physiology 26) 1989; 257:C270-6.
41. Canessa M, Brugnara C, Cusi D, Tosteson DC. Modes of operation and variable stoichiometry of the furosemide-sensitive Na and K fluxes in human red cells. J Gen Physiol 1986a; 87:113-42.
42. Halperin JA, Brugnara C, Kopin AS, Ingwall J, Tosteson DC. Properties of the Na+-K+ pump in human red cells with increased number of pump sites. J Clin Invest 1987; 80:128-37.
43. Godfrey K. Statistics in Practice: comparing the means of several groups. N Engl J Med 1985; 313:1450-6.
44. Gunther T, Vormann J. Na+-independent Mg2+ efflux from Mg2+-loaded human erythrocytes. FEBS Letters 1989; 247:181-4.
45. Feray JC, Garay R. A Na-stimulated Mg transport system in human red blood cells. Biochim Biophys Acta 1986; 856:76-84.
46. Feray JC, Beuzard Y, Garay RP. Na/Mg exchange in sickle cells. VI International Magnesium Symposium 1988; 22a.
47. Teste JF, Decelle T, Henrotte JG. Proprietes psychopharmacologiques de trois sels de magnesium pidolate, lactate et aspartate. Ann Pharmacol Fr 1995; 53:176-83.
48. Shalev O, Repka T, Goldfarb A, et al. Deferiprone (Ll) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 1995; 86:2008-13.
49. Jennings ML, Al-Rohil. Kinetics of activation and inactivation of swelling stimulated K/Cl transport. The volume sensitive parameter is the rate constant for inactivation. J Gen Physiol 1990; 95:1021-40.
50. Kaji DM, Tsukitani Y. Role of protein phosphatase in activation of K/Cl cotransport in human erythrocytes. Am J Physiol (Cell Physiology 29) 1991; 260:C176-80.
51. Forgac MD. Characterization of a Mg2+-stabilized state of the (Na+ and K+) stimulated adenosine triphosphatase using a fluorescent reporter group. J Biol Chem 1980; 255:1547-53.
52. Pedemonte CH, Beauge L. Inhibition of the (Na+ and K+) ATPase by magnesium ions and inorganic phosphate and release of these ligands in the cycles of ATP hydrolysis. Biochim Biophys Acta 1983; 748:245-53.
53. Dunham ET, Glynn IM. Adenosinetriphosphatase activity and the active movements of alkali metal ions. J Physiol 1961; 156:274-93.
54. Flatman PW, Lew VL The magnesium-dependence of sodium-pump-mediated socium potassium exchange in intact human red cells. J Physiol 1981; 315:421-46.
55. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995; 80-58-68.
56. Camaschella C, Gonella S, Calabrese R, et al. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes. Haematologica 1996; 81:397-403.